Daniel Kaemmerer

A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors

Mariano J. Alvarez, Prem S. Subramaniam, Laura H. Tang et al. · Nature Genetics · 2018 · 226 citations

Medicine, Oncology, Pharmacology +16

Comparison of immunoreactive score, HER2/<i>neu</i> score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms

Elisa Specht, Daniel Kaemmerer, Jörg Sänger et al. · Histopathology · 2015 · 182 citations

Medicine, Oncology, Pathology +17

Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours

Daniel Kaemmerer, Luisa Peter, Amelie Lupp et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 156 citations

Medicine, Nuclear Medicine, Oncology +16

Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms

Richard P. Baum, Harshad Kulkarni, Aviral Singh et al. · Oncotarget · 2018 · 139 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors.

Daniel Kaemmerer, Luisa Peter, Amelie Lupp et al. · PubMed · 2012 · 133 citations · Full text

Medicine, Nuclear Medicine, Oncology +17